TABLE 1.
Antibiotic (μg/ml)a | Antibiotic class | Relative malA-lacZ activityb |
---|---|---|
None | 1 | |
Trimethoprim (15)c | THF pathway inhibitord | 9.7 (0.4) |
Kanamycin (115) | Ribosomal inhibitor | 0.5 (0.1) |
Zeocin (1,200) | DNA intercalator | 1.5 (0) |
Mitomycin C (10) | DNA cross-linker | 4.3 (0.1) |
Sulfamethoxazole (3,000) | THF pathway inhibitor | 10 (0.7) |
Malleilactone (15) | Unknown | 12.3 (1.5) |
The concentration of antibiotic used is indicated in parentheses, and in each case, the concentration resulted in a 70 to 80% reduction in the growth yield, as determined by the OD600 taken at the time of β-galactosidase measurement.
Growth-adjusted β-galactosidase activity relative to that of the untreated control. The β-galactosidase activity and OD600 were determined after 24 h. The values are the means of the results of two independent experiments, with the range indicated in parentheses.
Trimethoprim was previously shown to activate malA-lacZ (11).
THF pathway, tetrahydrofolate reductase pathway.